Chemicals & Advanced Materials Global On demand · 24-48h

Global Fungal Xylanase Market Strategic Research Report

Global Fungal Xylanase Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Fungal Xylanase Market
$1962025
6.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Aspergillus Xylanase, Trichoderma Xylanase, Penicillium Xylanase

By Application: Feed, Food, Papermaking, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Novonesis (CPH: NZYM B, Bagsværd Denmark), DSM-Firmenich AG (SIX: DSFM, Kaiseraugst Switzerland), AB Enzymes GmbH (Unlisted, Darmstadt Germany), Merck KGaA (XTRA: MRK, Darmstadt, Germany), Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India), Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China), Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China), Enzyme Development Corporation (Unlisted, New York USA), Creative Enzymes (Unlisted, New York USA), Enzyme Innovation (Unlisted, Chino, California USA), Shandong Lonct Enzymes Co., Ltd. (Unlisted, Shandong China), Beijing Solarbio Science & Technology Co., Ltd. (Unlisted, Beijing China), Sunsonzyme (Unlisted, Beijing China), Jiangsu Yiming Biological Technology Co., Ltd. (Unlisted, Jiangsu China), Biolaxi Corporation (Unlisted, Maharashtra India)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 118 pages
Market size 2025
$196
Million USD
Forecast CAGR
6.2%
2025-2032
Forecast 2032
$298.6
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Fungal Xylanase market size is predicted to grow from US$ 196 million in 2025 to US$ 297 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.

Fungal xylanase is a biocatalyst developed for the efficient and specific degradation of xylan, an anti-nutritional factor or structural barrier widely present in plant materials. Through the irreplaceable biochemical action of specifically cleaving xylan chains, fungal xylanases have become a key tool for solving core bottlenecks in multiple industries: breaking down anti-nutritional factors and improving digestibility in feed; improving dough quality in baking; achieving green bleaching in papermaking; and releasing the value of waste resources in biorefining. They efficiently, safely, and economically achieve structural modification and upgrading of plant materials that are difficult to achieve using physical and chemical methods. The upstream supply chain mainly includes the selection and fermentation raw material supply of high-xylanase-producing fungal strains (such as Aspergillus niger and Trichoderma reesei); the downstream applications are widely used in the feed industry (improving grain digestibility), baking industry (improving dough and bread texture), juice clarification, papermaking biobleaching, and functional sugar preparation, forming a complete value chain from "strain research and development → industrial fermentation → multi-industry application". Its core value lies in utilizing the high specific activity and specificity of fungal enzymes to replace chemical methods with biological methods, achieving a dual improvement in economic and environmental benefits. In 2025, the production of fungal xylanase is expected to reach approximately 5,000 tons, with an average price of approximately US$40/kg, a gross profit margin of approximately 40%, and a single-line capacity of 100 tons/year.

Global key Fungal Xylanase players cover Novonesis (CPH: NZYM B, Bagsværd Denmark), DSM-Firmenich AG (SIX: DSFM, Kaiseraugst Switzerland), AB Enzymes GmbH (Unlisted, Darmstadt Germany), Merck KGaA (XTRA: MRK, Darmstadt, Germany), Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India), etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Fungal Xylanase market?

What factors are driving Fungal Xylanase market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Fungal Xylanase market opportunities vary by end market size?

How does Fungal Xylanase break out by Type, by Application?

This report presents a comprehensive overview of the global Fungal Xylanase market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Aspergillus Xylanase
  • Trichoderma Xylanase
  • Penicillium Xylanase

Segment by Enzymatic Mechanism

  • Endo-type Fungal Xylanase
  • Exo-type Fungal Xylanase

Segment by Application

  • Feed
  • Food
  • Papermaking
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Fungal Xylanase market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Feed, Food, Papermaking evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Fungal Xylanase Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$196
2025
Forecast
$298.6
2032
CAGR
6.2%
2025–2032
Regions
5
global
Key companies
Novonesis (CPH: NZYM BBagsværd Denmark)DSM-Firmenich AG (SIX: DSFMKaiseraugst Switzerland)AB Enzymes GmbH (UnlistedDarmstadt Germany)Merck KGaA (XTRA: MRKDarmstadt
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Aspergillus XylanaseTrichoderma XylanasePenicillium Xylanase
By Application
FeedFoodPapermakingOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Aspergillus Xylanase
  • 3.1.3 Trichoderma Xylanase
  • 3.1.4 Penicillium Xylanase
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Feed
  • 4.1.3 Food
  • 4.1.4 Papermaking
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Novonesis (CPH: NZYM B, Bagsværd Denmark)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 DSM-Firmenich AG (SIX: DSFM, Kaiseraugst Switzerland)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 AB Enzymes GmbH (Unlisted, Darmstadt Germany)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Merck KGaA (XTRA: MRK, Darmstadt, Germany)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Enzyme Development Corporation (Unlisted, New York USA)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Creative Enzymes (Unlisted, New York USA)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Enzyme Innovation (Unlisted, Chino, California USA)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Shandong Lonct Enzymes Co., Ltd. (Unlisted, Shandong China)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Beijing Solarbio Science & Technology Co., Ltd. (Unlisted, Beijing China)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Sunsonzyme (Unlisted, Beijing China)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Jiangsu Yiming Biological Technology Co., Ltd. (Unlisted, Jiangsu China)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Biolaxi Corporation (Unlisted, Maharashtra India)
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Fungal Xylanase market?
The global Fungal Xylanase market is estimated at US$ 196 million in 2025 (base year) and is projected to reach US$ 297 million by 2032.
How fast is the Fungal Xylanase market expected to grow?
The market is expected to grow at a CAGR of 6.2% from 2026 to 2032, expanding from US$ 196 million in 2025 to US$ 297 million in 2032, roughly 1.5 times its base-year value.
What does the Fungal Xylanase market cover?
Fungal xylanase is a biocatalyst developed for the efficient and specific degradation of xylan, an anti-nutritional factor or structural barrier widely present in plant materials. They efficiently, safely, and economically achieve structural modification and upgrading of plant materials that are difficult to achieve using physical and chemical methods.
How is the Fungal Xylanase market segmented by type?
By type, the market is segmented into Aspergillus Xylanase, Trichoderma Xylanase and Penicillium Xylanase.
What are the key applications of Fungal Xylanase?
Key applications covered include Feed, Food, Papermaking and Other.
Which companies are profiled in the Fungal Xylanase market report?
Key players profiled include Novonesis (CPH: NZYM B, Bagsværd Denmark), DSM-Firmenich AG (SIX: DSFM, Kaiseraugst Switzerland), AB Enzymes GmbH (Unlisted, Darmstadt Germany), Merck KGaA (XTRA: MRK, Darmstadt, Germany), Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India), Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China), Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China) and Enzyme Development Corporation (Unlisted, New York USA), among 15 companies covered in total.
What geographies does the Fungal Xylanase market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Fungal Xylanase?
What factors are driving Fungal Xylanase market growth, globally and by region?
What are the main risks and barriers in the Fungal Xylanase market?
Fungal xylanase is a biocatalyst developed for the efficient and specific degradation of xylan, an anti-nutritional factor or structural barrier widely present in plant materials.
Who should buy the Fungal Xylanase market report?
The report is intended for manufacturers and solution providers, distributors and end users in Feed, Food and Papermaking, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Fungal Xylanase market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.